Literature DB >> 30203088

Ethics and cloning.

Matti Häyry1.   

Abstract

Background: Scientists have cloned animals since the late 19th century, but the crucial step for ethics was the cloning of the first mammal by somatic cell nuclear transfer in 1997. This suggested that scientists could also clone, and possibly enhance, human beings. Sources of data: This survey examines ethical literature on cloning since the 1960s. Areas of agreement: The one ethical area of agreement in this issue is that we should not try to create new human beings by somatic cell nuclear transfer now. Areas of controversy: Ethicists disagree, however, on what justifies this norm. Some appeal to preference satisfaction and freedom from external constraints, others question this approach by more profound religious and moral considerations. Growing points: The discussion is currently not progressing, as the same arguments have been in use since the 1970s. Areas timely for developing research: Philosophers should prepare deeper analyses of the presuppositions of the ethical arguments used in the discussion before the issue surfaces again.

Entities:  

Mesh:

Year:  2018        PMID: 30203088     DOI: 10.1093/bmb/ldy031

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  2 in total

1.  Ethics of research on stem cells and regenerative medicine: ethical guidelines in the Islamic Republic of Iran.

Authors:  Leila Afshar; Hamid-Reza Aghayan; Jila Sadighi; Babak Arjmand; Seyed-Mahmoud Hashemi; Mohsen Basiri; Reza Omani Samani; Mohammad Kazemi Ashtiani; Seyed-Ali Azin; Ensiyeh Hajizadeh-Saffar; Ehsan Shamsi Gooshki; Amir-Ali Hamidieh; Mohammad-Reza Rezania Moallem; Seyed-Mohammad Azin; Sadegh Shariatinasab; Mehdi Soleymani-Goloujeh; Hossein Baharvand
Journal:  Stem Cell Res Ther       Date:  2020-09-14       Impact factor: 6.832

Review 2.  Chimeric Humanized Vasculature and Blood: The Intersection of Science and Ethics.

Authors:  Daniel J Garry; Arthur L Caplan; Mary G Garry
Journal:  Stem Cell Reports       Date:  2020-04-14       Impact factor: 7.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.